Dorothy Marie French
Veterinary at Michael Ct, San Carlos, CA
License number
Colorado 5141
Issued Date
Jun 15, 1990
Renew Date
Nov 1, 2016
Expiration Date
Oct 31, 2018
Type
Veterinarian
Address
Address
23 Michael Ct, San Carlos, CA 94070
Personal information
See more information about Dorothy Marie French at radaris.comName
Address
Phone
5011 Concord Rd, Sacramento, CA 95820
5210 San Francisco Blvd, Sacramento, CA 95820
5917 Echo St, Stockton, CA 95207
5908 Stanley Ave, Carmichael, CA 95608
3526 Carfax Ave, Long Beach, CA 90808
Professional information
See more information about Dorothy Marie French at trustoria.com
Novel Gene Disruptions, Compositions And Methods Relating Thereto
Novel Gene Disruptions, Compositions And Methods Relating Thereto
US Patent:
2009019, Aug 6, 2009
Filed:
Oct 18, 2005
Appl. No.:
11/577547
Inventors:
Fred de Sauvage - Foster City CA, US
Dorothy French - San Carlos CA, US
Lino Gonzalez - Menlo Park CA, US
Asja Praetor - Singapore, SG
Weilan Ye - Foster City CA, US
Katherin E. Combs - Spring TX, US
Zhiyong Ding - Longmont CO, US
Allison Anne Byers Horner - Dickinson TX, US
Erin Marie Massey - Conroe TX, US
Charles Montgomery - Jay OK, US
Laurie Jeanette Minze - Katy TX, US
Carolina Rangel - Houston TX, US
Tracy Ellen Willis Sevaux - Conroe TX, US
Mary Jean Sparks - Magnolia TX, US
Joy Anne Stala - The Woodlands TX, US
Peter Vogel - The Woodlands TX, US
Dorothy French - San Carlos CA, US
Lino Gonzalez - Menlo Park CA, US
Asja Praetor - Singapore, SG
Weilan Ye - Foster City CA, US
Katherin E. Combs - Spring TX, US
Zhiyong Ding - Longmont CO, US
Allison Anne Byers Horner - Dickinson TX, US
Erin Marie Massey - Conroe TX, US
Charles Montgomery - Jay OK, US
Laurie Jeanette Minze - Katy TX, US
Carolina Rangel - Houston TX, US
Tracy Ellen Willis Sevaux - Conroe TX, US
Mary Jean Sparks - Magnolia TX, US
Joy Anne Stala - The Woodlands TX, US
Peter Vogel - The Woodlands TX, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 39/395, G01N 33/00, C12N 5/10, C07K 16/18, A61P 27/00, A61P 25/00, A61P 25/18, A61P 25/22, A61P 37/00, A61P 13/12, A61P 3/00, A61P 19/00, A61P 9/00, A61P 35/00, A61P 41/00, A61P 3/10
US Classification:
4241581, 800 3, 435325, 435352, 5303871
Abstract:
The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO194, PRO220, PRO241, PRO284, PRO331, PRO354, PRO355, PRO533, PRO541, PRO725, PRO937, PRO1014, PRO1120, PRO1182, PRO1325, PRO1382, PRO1410, PRO1555, PRO1556, PRO1760, PRO1787, PRO1868, PRO4326, PRO4332, PRO4346, PRO4400, PRO6003, PRO6094, PRO6244, PRO9820, PRO9828, PRO10274, PRO16090, PRO19644, PRO21340, PRO92165, PRO85143, PRO1124, PRO1026 or PRO23370 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.
Compositions And Methods Relating To Stop-1
Compositions And Methods Relating To Stop-1
US Patent:
2011011, May 12, 2011
Filed:
Jul 28, 2010
Appl. No.:
12/845470
Inventors:
HEIDI ACKERLY - Belmont CA, US
Avi Ashkenazi - San Mateo CA, US
David Eberhard - San Francisco CA, US
Gretchen Frantz - San Francisco CA, US
Dorothy French - San Carlos CA, US
Germaine G. Fuh - Pacifica CA, US
Jo-Anne S. Hongo - Redwood City CA, US
Chingwei V. Lee - Foster City CA, US
Scot A. Marsters - San Carlos CA, US
Helga A. Raab - San Francisco CA, US
Evgeny Varfolomeev - San Bruno CA, US
Beni B. Wolf - Redwood City CA, US
Robert Maurice Pitti - El Cerrito CA, US
Liliana Soroceanu - San Francisco CA, US
Avi Ashkenazi - San Mateo CA, US
David Eberhard - San Francisco CA, US
Gretchen Frantz - San Francisco CA, US
Dorothy French - San Carlos CA, US
Germaine G. Fuh - Pacifica CA, US
Jo-Anne S. Hongo - Redwood City CA, US
Chingwei V. Lee - Foster City CA, US
Scot A. Marsters - San Carlos CA, US
Helga A. Raab - San Francisco CA, US
Evgeny Varfolomeev - San Bruno CA, US
Beni B. Wolf - Redwood City CA, US
Robert Maurice Pitti - El Cerrito CA, US
Liliana Soroceanu - San Francisco CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 16/18
US Classification:
5303873, 5303879
Abstract:
The present invention provides novel polypeptides, antibodies, antagonists, agonists, potentiators, nucleic acid molecules, compositions and methods relating to the STOP-1 polypeptide that are useful for treating and preventing diseases and for medical diagnosis and research. The present invention also provides consensus sequences and specific sequences for antibodies that specifically bind to STOP-1 that are useful in the methods described herein.
Compositions And Methods For The Diagnosis And Treatment Of Tumor
Compositions And Methods For The Diagnosis And Treatment Of Tumor
US Patent:
2005017, Aug 4, 2005
Filed:
Jul 2, 2004
Appl. No.:
10/884070
Inventors:
Avi Ashkenazi - San Mateo CA, US
Belinda Caims - Burlingame CA, US
Patrick Dowd - San Francisco CA, US
Gretchen Frantz - San Francisco CA, US
Dorothy French - San Carlos CA, US
Lino Gonzalez - Hollister CA, US
Paul Polakis - Burlingame CA, US
Victoria Smith - Burlingame CA, US
Beni Wolf - Redwood City CA, US
Thomas Wu - San Francisco CA, US
Zemin Zhang - Foster City CA, US
Belinda Caims - Burlingame CA, US
Patrick Dowd - San Francisco CA, US
Gretchen Frantz - San Francisco CA, US
Dorothy French - San Carlos CA, US
Lino Gonzalez - Hollister CA, US
Paul Polakis - Burlingame CA, US
Victoria Smith - Burlingame CA, US
Beni Wolf - Redwood City CA, US
Thomas Wu - San Francisco CA, US
Zemin Zhang - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C12Q001/68, G01N033/574, C07K014/82, C07H021/04
US Classification:
435006000, 435007230, 435069100, 435320100, 435325000, 530350000, 536023500
Abstract:
The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
Compositions And Methods Relating To Stop-1
Compositions And Methods Relating To Stop-1
US Patent:
7799899, Sep 21, 2010
Filed:
Apr 16, 2004
Appl. No.:
10/553491
Inventors:
Heidi Ackerly - Belmont CA, US
Avi Ashkenazi - San Mateo CA, US
David Eberhard - San Francisco CA, US
Gretchen Frantz - San Francisco CA, US
Dorothy French - San Carlos CA, US
Germaine G. Fuh - Pacifica CA, US
Jo-Anne S. Hongo - Redwood City CA, US
Chingwei V. Lee - Foster City CA, US
Scot A. Masters - San Carlos CA, US
Helga A. Raab - San Francisco CA, US
Evgeny Varfolomeev - Burlingame CA, US
Beni B. Wolf - Redwood City CA, US
Robert Maurice Pitti - El Cerrito CA, US
Liliana Soroceanu - San Francisco CA, US
Avi Ashkenazi - San Mateo CA, US
David Eberhard - San Francisco CA, US
Gretchen Frantz - San Francisco CA, US
Dorothy French - San Carlos CA, US
Germaine G. Fuh - Pacifica CA, US
Jo-Anne S. Hongo - Redwood City CA, US
Chingwei V. Lee - Foster City CA, US
Scot A. Masters - San Carlos CA, US
Helga A. Raab - San Francisco CA, US
Evgeny Varfolomeev - Burlingame CA, US
Beni B. Wolf - Redwood City CA, US
Robert Maurice Pitti - El Cerrito CA, US
Liliana Soroceanu - San Francisco CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 16/00
US Classification:
5303871, 4241301
Abstract:
The present invention provides novel polypeptides, antibodies, antagonists, agonists, potentiators, nucleic acid molecules, compositions and methods relating to the STOP-1 polypeptide that are useful for treating and preventing diseases and for medical diagnosis and research. The present invention also provides consensus sequences and specific sequences for antibodies that specifically bind to STOP-1 that are useful in the methods described herein.
Methods Of Treating Fgfr3 Related Conditions
Methods Of Treating Fgfr3 Related Conditions
US Patent:
2014003, Jan 30, 2014
Filed:
Jul 26, 2013
Appl. No.:
13/952072
Inventors:
Dorothy French - San Carlos CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 39/395, G01N 33/574
US Classification:
4241331, 4241721, 4241431, 4241421, 435 723, 514 44 R
Abstract:
Provided herein are biomarkers and therapies for the treatment of pathological conditions, such as cancer, and method of using FGFR3 antagonists. In particular, provided is FGFR3 as a biomarker for patient selection and prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
Polynucleotide Encoding An Anti-Fgf19 Antibody
Polynucleotide Encoding An Anti-Fgf19 Antibody
US Patent:
7846691, Dec 7, 2010
Filed:
Jan 22, 2010
Appl. No.:
12/692468
Inventors:
Luc Desnoyers - San Francisco CA, US
Dorothy French - San Carlos CA, US
Dorothy French - San Carlos CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C12N 5/10, C12N 15/13, C12N 15/63, C12N 15/64
US Classification:
435 696, 435325, 4352523, 4353201, 536 2353
Abstract:
The invention provides anti-FGF19 antibodies, and compositions comprising and methods of using these antibodies, methods using anti-FGF19 antibodies, and methods comprising detection of FGF19 and/or FGFR4.
Copi Molecules And Uses Thereof
Copi Molecules And Uses Thereof
US Patent:
2011004, Feb 24, 2011
Filed:
Jun 29, 2010
Appl. No.:
12/826537
Inventors:
David Dornan - Burlingame CA, US
Dorothy French - San Carlos CA, US
Vishva Dixit - Los Altos CA, US
Dorothy French - San Carlos CA, US
Vishva Dixit - Los Altos CA, US
International Classification:
C12Q 1/68, C12Q 1/00, G01N 33/53
US Classification:
435 6, 435 4, 435 71, 435 78
Abstract:
The invention provides diagnostic, prognostic, and therapeutic uses for detecting COP1 overexpression in a variety of cancers. The methods and uses can further include detecting p53 expression. The invention also provides reagents and kits for use in screening for test compounds that interfere with COP1 and p53 binding.
Anti-Fgfr4 Antibodies And Methods Of Use
Anti-Fgfr4 Antibodies And Methods Of Use
US Patent:
2014003, Feb 6, 2014
Filed:
Oct 4, 2013
Appl. No.:
14/046659
Inventors:
Luc Desnoyer - San Francisco CA, US
Dorothy French - San Carlos CA, US
Dorothy French - San Carlos CA, US
Assignee:
GENENTECH, INC. - SOUTH SAN FRANCISCO CA
International Classification:
C07K 16/28, A61K 45/06, A61K 39/395
US Classification:
4241331, 5303898, 5303873, 53038822, 536 2353, 435334, 435 702, 5303917, 4241721, 4241431
Abstract:
The invention provides anti-FGFR4 antibodies and methods of using the same.
Methods Of Using Fgf19 Modulators
Methods Of Using Fgf19 Modulators
US Patent:
2013018, Jul 18, 2013
Filed:
Jan 18, 2013
Appl. No.:
13/745647
Inventors:
Donna M. Dambach - San Francisco CA, US
Dorothy French - San Carlos CA, US
Veronique V. Lauriault - San Francisco CA, US
Dorothy French - San Carlos CA, US
Veronique V. Lauriault - San Francisco CA, US
Assignee:
GENENTECH, INC. - South San Francisco CA
International Classification:
C12Q 1/68, A61K 39/395
US Classification:
4241331, 435 611
Abstract:
Provided herein are methods of using FGF19 modulators and/or bile acid metabolism biomarkers.
Cop1 Molecules And Uses Thereof
Cop1 Molecules And Uses Thereof
US Patent:
7785815, Aug 31, 2010
Filed:
Apr 10, 2007
Appl. No.:
11/786399
Inventors:
David Dornan - Burlingame CA, US
Dorothy French - San Carlos CA, US
Vishva Dixit - Los Altos CA, US
Dorothy French - San Carlos CA, US
Vishva Dixit - Los Altos CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
G01N 33/53, C12Q 1/68
US Classification:
435 723, 435 6, 436536, 436518
Abstract:
The invention provides diagnostic, prognostic, and therapeutic uses for detecting COP1 overexpression in a variety of cancers. The methods and uses can further include detecting p53 expression. The invention also provides reagents and kits for use in screening for test compounds that interfere with COP1 and p53 binding.